A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance
This study is currently recruiting participants.
Verified June 2011 by Centers for Disease Control and Prevention, China
Sponsor:
Centers for Disease Control and Prevention, China
Collaborator:
Merck
Information provided by:
Centers for Disease Control and Prevention, China
ClinicalTrials.gov Identifier:
NCT01042652
First received: January 4, 2010
Last updated: June 14, 2011
Last verified: June 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | June 2012 |
| Estimated Primary Completion Date: | January 2012 (Final data collection date for primary outcome measure) |